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Abstract 
In the last few years, great progress has been made to validate tissue engineering strategies in 
preclinical studies and clinical trials on the regeneration of osteochondral defects. In the 
preclinical studies, one of the dominant strategies comprises the development of 
biomimetic/bioactive scaffolds, which are used alone or incorporated with growth factors and/or 
stem cells. Many new trends are emerging for modulation of stem cell fate towards osteogenic 
and chondrogenic differentiations, but bone/cartilage interface regeneration and physical 
stimulus have been showing great promise. Besides the matrix-associated autologous 
chondrocyte implantation (MACI) procedure, the matrix-associated stem cells implantation 
(MASI) and layered scaffolds in acellular or cellular strategy are also applied in clinic. This 
review outlines the progresses at preclinical and clinical levels, and identifies the new challenges 
in osteochondral tissue engineering. Future perspectives are provided, e.g., the applications of 
extracellular matrix-like biomaterials, computer-aided design/manufacture of osteochondral 
implant and reprogrammed cells for osteochondral regeneration. 
 
Keywords: Osteochondral tissue engineering; Layered scaffold; Biomimetic; Interface 
engineering; Clinical trial, Pluripotent stem cells 
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Introduction 
Articular cartilage is a connective tissue that acts as a shock absorber and facilitates joint’s 
motion in low friction.1 Many reasons can lead to cartilage lesions, such as traumatic events, 
chronic repetitive microtrauma, and aging. Cartilage lesions are normally irreparable due to the 
typical avascular nature of cartilage and consequent lack of supplementation of potentially 
reparative cells/bioactive factors.2 As the cartilage lesion progresses, it extends to the underlying 
subchondral bone and osteochondral defect (OCD) appears. Other diseases originating from the 
subchondral bone and subsequently reaching the cartilage layer can also induce OCD, such as 
osteochondritis dissecans and osteonecrosis.3 Osteochondral (OC) fracture, which is a common 
injury in children and adolescents, represents one cause for OCD. Besides the OCD in the knee, 
nowadays an increasing amount of attention is being given to OC lesions of the talus (OLTs) 
because they primarily affect young athletic population and often lead to long-term disability.4, 5 
Similarly, OC fractures of the patella represent a major complication following patellar 
instability or dislocation.6 OCD often causes the formation of fibrocartilage which only provides 
poor protection to the subchondral bone. Subsequent degradation of the repaired and adjacent 
tissues is often observed.2 Furthermore, OCD is associated with severe pain, impaired joint 
mobility and low quality of life. It also generates huge amount of health care costs every year. In 
the United States alone, the annual cost for the treatment of OCD is about $95 billion.7  
    There has been increased evidence that without the support from the subchondral bone, any 
treatment of the cartilage layer is likely to fail.3, 8 Thus, the cartilage and subchondral bone 
should be taken into account as one unit during OC regeneration, instead of being considered 
separately. Actually, the cartilage layer and subchondral bone are tightly connected. No matter 
what type of the lesion it is, either from the cartilage or from the subchondral bone, the 
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connected and surrounding tissues will always be affected, contributing negatively to the 
mechanical homeostasis of the whole joint. Therefore, the main goal for OC regeneration is to 
restore its biomechanical properties, besides the regeneration of the defect.  
    Currently, there are several methods used in the clinical setting for treating OCD. 
Arthroscopic debridement is used to trim the loose cartilage in small defects and only for the 
relief of pain for the patients. For defects between 1 and 2.5 cm2, microfracture is commonly 
selected.9 For this method, microfractures are created from the cartilage defect until reaching the 
subchondral bone. The access of mesenchymal stem/stromal cells (MSCs) and growth factors 
from bone marrow and blood facilitates the formation of fibrocartilage on the defect. Patients 
who received this treatment often need revision interventions after some time, i.e. some 
degradation of the tissue was reported around 18 months post-operatively. Arthroscopic 
debridement and microfracture are palliative methods for OCD treatment. OC autograft 
transplantation (mosaicplasty, OATS) constitutes another option if the defect size is between 1 
and 4.0 cm2.10, 11 However, this method would create new OCD in the body and has limited 
availability of the donor tissues. For lesions of size higher than 2.5 cm2, autologous chondrocyte 
implantation (ACI) technology has been widely used. This method presents an advantage of 
possibly achieving regeneration with hyaline cartilage. However it requires two-step surgeries 
and may induce complications of chondrocyte apoptosis and necrosis, or hypertrophy of the 
cells.12, 13 
    Recently, tissue engineering strategy emerged as a promising alternative to regenerate OCD.14 
Tissue engineering is a multi-disciplinary approach, involving the advances in material science, 
chemical engineering, biology, and medicine.15 Probably the currently most appealing clinical 
application of tissue engineering for OC regeneration is the matrix-associated autologous 
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chondrocyte implantation (MACI) technology.16 In order to achieve ideal OC regeneration, 
numerous efforts have been made on scaffold/hydrogel development, stem cells differentiation, 
growth factors incorporation, and animal models.14, 17-19 Furthermore, a few studies have been 
extended to clinical trials.20-22 Many important and interesting findings were made, and some 
new technologies and subjects have emerged during the last few years.23-25  
In this review, the most important breakthroughs in OC tissue engineering in the past few 
years were overviewed. Moreover, this review also intends to add new insights regarding the 
current research status and challenges in OCD preclinical studies and clinical trials using tissue 
engineering strategies. In addition, the new trends and future directions in OC tissue engineering 
are briefly discussed. 
 
Tissue Engineering Strategies in OC Regeneration 
In Vitro Studies on OC Tissue Engineering 
Biomaterials, bioactive agents, and cells are the three key factors for tissue engineering strategy. 
A lot of biomaterials have been explored for OC regeneration in vitro. These materials include 
synthetic or natural polymers, bioceramics, and composites of these materials.26-29 It is necessary 
to study the biological performances of these materials by in vitro cell culture after processing 
them into different formats, such as porous scaffolds and hydrogels of non-layered or layered 
structure.30-32 
 
Layered scaffolds 
As a stratified tissue, OC tissue is composed of collagen (Col) II and glycosaminoglycan (GAG) 
in the hydrogel-like cartilage layer, and hydroxyapatite (HA) and Col I in the highly porous 
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subchondral bone layer.26 Inspired by the structure and components of OC tissue, biomimetic 
strategies have been introduced to produce scaffolds displaying similar structural or chemical 
properties to OC tissue.26 For example, layered constructs which presented similar 
microenvironments to the corresponding layers of OC tissue were studied intensively.26, 33, 34  
    Oliveira et al. developed a well-integrated bilayered porous HA and chitosan scaffold.26 
Osteogenic differentiation (14 days) and chondrogenic differentiation (28 days) of goat bone 
marrow mesenchymal stromal cells (BMSCs) were performed on the separated HA and chitosan 
layers, respectively. Results showed that the alkaline phosphatase (ALP) content increased in the 
HA scaffolds after 2 weeks osteogenic differentiation. Osteopontin and Col I were also observed 
in the HA scaffolds via the immunofluorescence labeling.  The chitosan scaffolds presented 
enhanced GAG content from day 7 to 21. In another study, multilayered porous scaffolds were 
developed which consisted of gradient HA content between the collagen and the collagen/HA 
layers.34 Human BMSCs (hBMSCs) were seeded onto the separated collagen and collagen/HA 
layers, and then both the chondrogenic differentiation (28 days) and osteogenic differentiation 
(14 days) of the cells were performed for these two groups of scaffolds, respectively. The 
chondrogenic differentiation results showed that the collagen layer induced superior 
chondrogenic genes (Sox-9, Col 2a1 and aggrecan) expressions compared with the collagen/HA 
layer at day 21. Furthermore, the GAG contents in the collagen layer were higher than the ones 
in the collagen/HA layer at day 14 and 28.  In case of osteogenic differentiation, the collagen/HA 
layer showed superior ALP content at day 5, 10 and 13, and displayed higher amounts of Runx-
2, ALP, Col 1a1, osteopontin and osteocalcin genes at day 14, compared with the ones of the 
collagen layer.  
Page 6 of 61
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 7
    Mimicking the micromechanical environment of OC tissue, hydrogels and porous scaffolds 
were combined to form bilayered scaffolds.31, 32, 35 In one study from Hung et al., agarose with 
encapsulated bovine chondrocytes was penetrated into the devitalized bovine tibia trabecular 
bone to generate the cylindrical bilayered OC construct.35 The constructs were cultured in 
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) and 50 µg/ml ascorbic acid for 42 days. They also produced chondrocytes-seeded agarose 
of anatomical patellar shape and then integrated the agarose constructs with trabecular bone of 
corresponding anatomical shape to form the osteochondral constructs which were subsequently 
cultured in the above mentioned medium for two weeks. Results showed that the chondrocytes 
were viable in these two experiments and the agarose still firmly integrated with the bony 
substrate during the culture time periods. These constructs presented positive Col II staining, as 
well as enhanced GAG contents and mechanical properties. In a following study, hBMSCs were 
pre-differentiated into chondrocytes and osteoblasts for 1 week firstly and then these cells were 
incorporated into the agarose (chondrocytes) layer and decellularized trabecular bone layer 
(osteoblasts) of the bilayered scaffolds, respectively.32 Undifferentiated hBMSCs were used as 
control and seeded into the same bilayered scaffolds. The constructs were placed into perfusion 
bioreactors and cultured in either chondrogenic medium or cocktail medium containing 
chondrogenic and osteogenic supplements for 5 weeks. The control constructs were kept under 
static or bioreactor culture in the chondrogenic or cocktail medium for 5 weeks.  It was found 
that pre-differentiated BMSCs only favored bone formation, while the perfusion condition and 
cocktail medium inhibited chondrogenesis of BMSCs. The perfusion bioreactor was helpful to 
improve the integration of bone-cartilage interface. In order to further efficiently guide the cells 
toward OC differentiate, new culture technologies should be explored. 
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Biological cues 
It has been reported that some growth factors or drugs are efficient in modulation of cellular 
differentiation. For example, transforming growth factor-β1 (TGF-β1) or transforming growth 
factor-β3 (TGF-β3) can induce chondrogenesis of the MSCs, and bone morphogenetic proteins 
(BMP) are suitable for guiding the osteogenesis of MSCs.36, 37 These bioactive reagents have 
been introduced into the scaffolds to improve the cellular differentiation toward OC 
regeneration.  
    Guo et al. developed bilayered poly(ethylene glycol) fumarate hydrogels (OPF) which 
contained gelatin microparticles loaded with TGF-β1 in the chondral layer.28 The chondral layer 
encapsulated undifferentiated rabbit BMSCs, while the bony layer consisted of rabbit BMSCs or 
osteogenically differentiated BMSCs (6 days). Bilayered hydrogels only with BMSCs and un-
loaded microparticles, or bilayered hydrogels with BMSCs in the chondral layer and 
osteogenically differentiated BMSCs in the bony layer and blank microparticles, were used as 
controls. All the constructs were cultured in chondrogenic medium supplemented with β-glycerol 
phosphate (β-GP) for 28 days. The results showed that chondrogenesis was observed in the 
chondral layer, especially in the presence of TGF-β1. In the bony layer, osteoblastic phenotype 
of the cells was maintained. Calcium deposition was limited, but this layer promoted 
chondrogenic differentiation of BMSCs in the chondral layer. The optimal results were displayed 
in the group with growth factor loaded microparticles and osteogenic differentiated BMSCs. In 
another similar study, gelatin microparticles loaded with rabbit BMSCs and TGF- β3 were 
incorporated into the chondral layer of the bilayered OPF hydrogels.36 BMSCs undergone varied 
osteogenic differentiation time periods (0, 3, 6, 12 days) were encapsulated into the bony layer of 
the bilayered OPF hydrogels. Bilayered hydrogels including chondral layer without growth 
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factor but bony layer with BMSCs of varied osteogenic differentiation time were used as 
controls. All the bilayered constructs were cultured in chondrogenic medium plus β-GP for 28 
days. In the chondral layer, TGF-β3 significantly promoted chondrogenic differentiation of 
BMSCs. Osteogenically differentiated cells along with TGF-β3 improved the chondrogenic gene 
expression of the BMSCs. In the bony part, cells maintained ALP activity during coculture, 
while mineralization was delayed in the presence of TGF-β3.  
    Spatiotemporal modulation of the delivery of growth factors in the scaffolds is essential for 
guiding the BMSCs differentiation during OC regeneration. Bone morphogenetic protein-2 
(BMP-2) and TGF-β1 loaded poly(lactic-co-glycolic acid) (PLGA) microspheres were used to 
fabricate microsphere based PLGA scaffolds with opposite gradient of the two growth factors by 
Dormer et al.37 Human BMSCs (hBMSCs) or human umbilical cord mesenchymal stromal cells 
(UCMSCs) were seeded onto these scaffolds. The constructs were cultured in defined DMEM 
for the first three days and then in defined medium supplemented with β-GP and dexamethasone 
for 6 weeks. Blank scaffolds, single phase scaffolds (with BMP-2 or TGF- β1), or biphasic 
scaffolds (with BMP-2 or TGF- β1 in each layer) were used as controls. The results 
demonstrated that the hBMSCs responded well to the gradient design through their gene 
expressions (Col I, Sox9 and Runx2), but there were no significant differences compared with 
UCMSCs in terms of the biochemical performances (DNA, GAG, ALP and hydroxyproline 
contents). The gradient scaffolds produced regionalized extracellular matrix (ECM), and were 
superior as compared with the blank control scaffolds in cellular number, GAG production, 
collagen content, and ALP activity. In another study, Wang et al. incorporated recombinant 
human BMP (rhBMP) and recombinant human insulin-like growth factor-1 (rhIGF-1) in PLGA 
or silk microparticles.38 Next, these growth factors were distributed in cylindrical alginate gels or 
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aqueous derived salt-leached silk scaffolds with a gradient concentration of one growth factor or 
reverse gradient concentrations of these two growth factors.  The influences of the gradient 
concentration of the growth factors on hBMSCs were investigated by seeding the cells onto the 
scaffolds or encapsulating the cells in the gels. The constructs were cultured in medium 
containing osteogenic and chondrogenic components for 5 weeks. In the case of alginate gels, it 
was found that silk microspheres were more efficient in rhBMP-2 delivery and less efficient in 
delivering rhIGF-1 compared with PLGA microspheres. The growth factor gradients induced 
non-gradient trends in hMSCs OC differentiation, due to shallow gradients. Regarding the silk 
scaffold group, the cells presented osteogenic and chondrogenic differentiations along the 
gradient concentration of rhBMP-2 or reverse gradient of rhBMP-2/rhIGF-1, but not in the 
rhIGF-1 gradient system.  
    The above mentioned studies provide useful insights for OC regeneration, as well as for 
creation of complex tissues. In the future, development of growth factors of low cost, such as 
from human platelet releasate, would be of great interest.39 
 
Stem cells 
Besides primary cells (osteoblasts and chondrocytes), increasing attention has been shifted to 
stem cells for OC regeneration, such as BMSCs, adipose tissue-derived stem cells (ADSCs), 
UCMSCs and amniotic fluid-derived stem cells (AFSCs).26, 40-42  
    In the studies from Guo et al., the osteogenically pre-differentiated BMSCs were encapsulated 
in the OPF hydrogels and the cells maintained their osteoblastic phenotype and ALP activity, 
even though the calcium deposition was limited or delayed.28, 36 Dormer et al. compared the 
human BMSCs and UCMSCs by seeding them in growth factor loaded PLGA scaffolds and 
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found that there were no significant differences between these cells regarding biochemical 
performances.37 ADSCs were seeded onto the electrospun poly(ε-caprolactone) (PCL) scaffolds 
with opposite gradient concentrations of insulin and β-GP, and the constructs were cultured for 8 
weeks.40 The results showed that chondrogenic differentiation of the cells increased in the 
insulin-rich region and mineralization matrix enhanced at β-GP rich domain. In another study, 
AFSCs were encapsulated into agarose gels (chondral layer) or seeded onto the starch-PCL 
(SPCL) scaffolds (bony layer) and subsequently the constructs underwent chondrogenic or 
osteogenic differentiations, respectively.42 After chondrogenic and osteogenic differentiations 
occurring, the agarose and SPCL constructs were integrated by agarose solution and the formed 
bilayered constructs were cultured under OC co-culture medium or OC co-culture medium plus 
insulin-like growth factor-1 (IGF-1) for 2 weeks. Basic amniotic fluid cell medium was used as 
control. Results displayed that osteogenically pre-differentiated AFSCs did not need further OC 
medium to maintain their phenotype, while the chondrogenically pre-differentiated ones still 
required OC medium (without IGF-1) to maintain their phenotypes. 
     
Interface regeneration 
During OC regeneration, most of the attention has been given to the generation of the integrated 
cartilage layer and the subchondral layer. Only recently, there is increased awareness that the 
regeneration of the interface between chondral and subchondral bone also plays an important 
role in OC tissue engineering.23 The OC interface is a calcified cartilage layer located between 
the hyaline cartilage and the subchondral bone.23, 35, 43 The hypertrophic chondrocytes and 
extracellular matrix rich in Col I, II, and X, are the unique properties of this layer. The OC 
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interface acts as a barrier minimizing the diffusions of fluids between cartilage layer and 
subchondral layer, and therefore prevents the invasion of vessels from bone. 
    Bioactive inorganic biomaterials have been used to direct the differentiation of chondrocytes 
toward the formation of calcified cartilage. In the study from Jiang et al., agarose gel with 
encapsulated bovine chondrocytes was firstly integrated with PLGA/bioactive glass microsphere 
scaffold and then bovine osteoblasts were subsequently seeded onto the PLGA/bioactive glass 
part.44 These multi-phased OC constructs contained a hybrid gel/microsphere interface region 
between the gel (chondral) and scaffold (bony) layers. The constructs were cultured in DMEM 
plus ascorbic acid for 20 days. Constructs without bioactive glass were used as control. It was 
found that the co-culture of chondrocytes and osteoblasts resulted in three distinct yet continuous 
regions: cartilage, calcified cartilage and bone-like matrices. The PLGA/bioactive glass phase 
facilitated the formation of calcified interface and promoted chondrocyte mineralization potential 
around the interface region. Khanarian et al. incorporated bovine deep zone chondrocytes into 
alginate gels with 1.5 wt/v% HA particles (20 µm).45 The constructs were cultured for 4 weeks in 
DMEM supplemented with ITS Premix, proline and ascorbic acid. Constructs without HA were 
used as control. The results showed that the HA phase enhanced the formation of GAG and Col 
II, and also increased mechanical properties as compared with the control. Presence of HA 
promoted hypertrophy of the chondrocyte, as well as Col X deposition in the constructs. In 
another study from the same group, the authors encapsulated bovine deep zone chondrocytes and 
triiodothyronine (T3)-induced hypertrophic deep zone chondrocytes in agarose/HA hybrid gels 
to mimic the calcified cartilage formation. They studied the different influences of nano-sized 
and micro-sized HA particles on the hypertrophy of chondrocytes.43 The constructs were 
cultured for 14 days in DMEM supplemented with ITS Premix, proline and ascorbic acid. 
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Acellular hybrid gels were used as control (Figure 1). It was found that the hypertrophic 
chondrocytes presented higher ECM and mineral deposition in the presence of HA compared   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The influence of HA on hypertrophic chondrocytes after culturing in agarose/HA gels 
for 14 days. (A) Effect of HA presence (1.5 w/v% HA) and size (micro and nano-sized) on the 
biosynthesis and mineralization. Alcian Blue stain (GAG) revealed abundant matrix for the 
micro-HA group. The immunohistochemistry analysis showed positive Col II and minimal Col I 
stainings for all the groups, while positive Col X staining was found in the HA containing groups 
no matter the particle size. Strongly positive mineral staining was seen in the micro-HA group 
(Alizarin Red and Von Kossa). (B) Effect of HA presence and size on the gene expressions. Both 
Col X and Ihh expression were upregulated. (C) Effect of HA dose (micro-sized) on the gene 
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expressions. A dose-dependent increase in Col X expression was found. Suppression of PTHrP 
and Ihh expressions were found at the higher HA doses (3% and 6% HA, *p < 0.05, n=3 
normalized to 0% group). Adapted from Reference (43), with permission from Elsevier. 
 
with non-induced chondrocytes. Higher compressive and shear mechanical properties were 
observed in the constructs as compared with the acellular ones. Cell hypertrophy was 
independent of ceramic size, while higher ECM deposition was only displayed in the micro-sized 
HA group. Allan et al. firstly seeded cow deep zone chondrocytes on top of the calcium 
polyphosphate (CPP) scaffolds and then cultured the constructs in DMEM supplemented with 
ascorbic acid.46 At day 7, β-GP was added in the medium and the culture was continued up to 8 
weeks. Control culture was without β-GP. The results showed that cartilage tissue formed and 
presented two zones, one calcified region adjacent to the CPP scaffold and a hyaline-like zone on 
the surface. Little or no mineral was observed in the absence of β-GP. The mineral in the 
calcified region was HA. The formed cartilage tissue possessed significantly higher stiffness and 
interfacial shear properties compared with the control. 
Besides the primary cells, stem cells have also been investigated for OC interface 
regeneration.47 Cheng et al. encapsulated rabbit BMSCs into collagen microspheres and then 
cultured the microspheres under chondrogenic or osteogenic conditions for 21 days.23 Following, 
microspheres of each group were packed and glued for continued co-culture for another 21 days. 
The resulted disc-like chondrogenic and osteogenic aggregates were glued together by a middle 
layer of collagen gel containing undifferentiated BMSCs.  The tri-layered collagen microsphere 
scaffolds were co-cultured under normal, chondrogenic or osteogenic medium for 14 or 21 days. 
When co-culture was performed in the chondrogenic medium, the results showed that an intact 
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and continuous calcified cartilage zone was formed separating the upper chondrogenic layer and 
the underlying osteogenic layer. Cells at the interface region presented hypertrophic phenotype. 
Col II and X, calcium mineral and vertically oriented fibers were presented in the ECM. In the 
case of osteogenic medium, the upper layer chondrogenic tissue became calcified. In the normal 
medium, undifferentiated BMSCs were found in the interface, and the pre-differentiated BMSCs 
were able to maintain their chondrogenic or osteogenic phenotypes. UCMSCs were applied for 
OC regeneration via a sandwich strategy by Wang et al.41 The human UCMSCs were firstly 
cultured in the PLLA scaffolds and underwent chondrogenic or osteogenic differentiation for 3 
weeks. Then, the chondrogenic and osteogenic constructs were sutured together with one layer of 
highly concentrated and undifferentiated UCMSCs solution in the interface. The constructs were 
cultured in DMEM low glucose supplemented with dexamethasone and IGF-1 for another 3 
weeks. Two chondrogenic constructs, two osteogenic constructs, or one chondrogenic and one 
osteogenic constructs were sutured (all the three groups without cells in the interface) and used 
as controls. Results revealed that the chondrogenesis and osteogenesis of UCMSCs before 
suturing were confirmed by the expression of Col II and Runt-related transcription factor 2 
genes, respectively. Increased ECM secretion was observed during the co-culture. The 
histological and immunohistochemical stainings (GAG, Col I and calcium) results showed that 
the OC constructs with one layer undifferentiated cells in the interface presented better 
integration and transition in the constructs as compared with the controls.  
    Co-culture approach of BMSCs and osteoblasts was introduced for osteochondral interface 
generation. Chen et al. seeded the rabbit BMSCs in silk scaffolds and placed the constructs in 
chondrogenic medium for one week.48 Meanwhile, rabbit osteoblasts were cultured in the cell 
culture plate. Afterwards, the three-dimensional (3D) constructs and the two-dimensionally (2D) 
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cultured osteoblasts were co-cultured in chondrogenic medium for 3 weeks by contacting them 
together. Non-co-cultured 3D constructs were used as control. The results demonstrated that 
moderate downregulation of chondrogenic marker genes (such as Col II and Aggrecan) was 
observed in comparison with the control group. But the Sox-9 and Col I expressions increased. 
Only the chondrogenic BMSCs layer in contact with the osteoblasts expressed OC interface 
markers, such as Col X and MMP-13, which were not observed in the control group.  
    As these studies bring new insights into OC regeneration, further efforts on controlling the 
thickness and improving the strength of the interface should be considered. 
 
In Vivo Studies on OC Tissue Engineering 
After the in vitro biological performance examination, the biomaterials should be evaluated by 
the in vivo studies before going for the clinical trials. Compared with the simplified and 
optimized culture conditions of the in vitro study, the in vivo study provides more complex 
environments and thus closely mimics the real scenario of OC tissue. In the literature, it was 
found that rabbit was a popular animal model for creation of OCD.36 Larger animal models were 
also used, such as pigs.49  Subcutaneous implantation models were also used to screen ectopic 
formation of the tissues.50 In OCD model, majority of the studies selected femoral condyles in 
the knee as the implantation sites. OCD created in patella groove or trochlear groove was also 
popular model. The in vivo studies offer important information for the selection of biocompatible 
materials, optimization of scaffold/hydrogel component or structure, determination of the release 
profiles of bioactive reagents, etc. The following will discuss several important aspects in the in 
vivo studies on OC regeneration. 
Materials intrinsic and structural properties 
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The intrinsic and structural properties of biomaterials could affect the OC regeneration. The 
intrinsic properties of biomaterials (such as the purity, chemical groups, molecular weight and 
monomer ratio) are critical for the immune response of the host cells, the recruitment of the 
reparative cells, and the formation of new tissues.  
    Igarashi et al. combined rabbit autologous BMSCs with alginate gels of different grades for 
the regeneration of rabbit patellar groove OCD for 4 and 12 weeks.51 It was found that the ultra-
purified alginate group demonstrated better histological and mechanical outcomes compared 
with commercial alginate groups. Freeze-dried chitosan scaffolds of different molecular weights 
(349.3, 507.4, 510.6, 7.9, 10.3, and 11.49 kDa) and deacetylation degrees (91% and 83%) were 
investigated by Abarrategi et al. via implantation them in rabbit medial femoral condyle OCD 
model for 3 months.52 Better subchondral bone regeneration and noticeable cartilaginous tissue 
regeneration were observed in chitosan scaffolds of intact mineral content, 83% deacetylation 
degree and 11.49 kDA molecular weight in contrast with other groups. Jansen et al. compared 
scaffolds prepared from copolymers comprised of varied poly(ethylene oxide terephthalate) 
(PEOT) and poly(butylene terephthalate) (PBT) block ratios for OC regeneration in rabbit medial 
femoral condyle for 12 weeks.53 When PEOT/PBT was 70/30, the scaffolds mainly consisted of 
cartilage-like tissue on top of the trabecular bone. While decreasing the PEOT/PBT ratio to 
55/45, the scaffolds comprised mainly of cancellous bone.  
Structural properties of biomaterials also play important roles in their in vivo biological 
performances for OC regeneration, such as porosity, pore size and format. Ikeda et al. compared 
PLGA scaffolds of different porosities (80%, 85%, and 92%) by implantation the scaffolds in 
rabbit patellar groove OCD for 6 and 12 weeks time periods.54 It was found that, scaffolds of 
85% and 92% porosities presented significant higher histological scores than the scaffolds of 
Page 17 of 61
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 18
80% porosity at both time points. The higher porosity allowed better migration of the MSCs. On 
the other hand, the pore size effect on OC regeneration was investigated by Duan et al.55 
Bilayered PLGA scaffolds of the same porosity (85%) but with different pore sizes in the 
chondral and bony layers (50-100 µm, 100-200 µm, 200-300 µm and 300-450 µm) were 
developed. The scaffolds were seeded with allogenic rabbit BMSCs and the constructs were 
cultured for 7 days before implantation in rabbit femoral condyle for 6 and 12 weeks. They 
found that pore size between 100-200 µm was beneficial for chondral repair and the one between 
300-450 µm was good for bone regeneration. Hui et al. rehydrated the previously freeze-dried 
OPF hydrogels and then implanted them in load-bearing regions of lateral and medial condyle 
OCD in 8 months old pigs for 2 and 4 months.49 It was found the scaffold induced neotissue 
filling to 58% and 54% after 2 and 4 months, respectively. Newly formed hyaline cartilage made 
up 39% of the neotissue after 4 months, but without inducing subchondral bone regeneration.  
By analysis of the in vivo study results, we can select the most suitable component and the 
best structure for further study. 
 
Bioactive scaffolds 
Development of bioactive scaffolds without growth factors is an attractive approach for OC 
regeneration due to the low cost and simple processing procedure. ECM based scaffold could be 
a good choice for this purpose. ECM, which is produced by the host cells, contains bioactive 
molecules for driving tissue regeneration and provides biomimetic microenvironments for 
cellular homing. There were successful reports on ECM application in clinic, such as 
cardiovascular and muscle.56, 57 The ECM based scaffolds can be vitalized or devitalized tissues.  
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    Emans et al. ectopically created cartilage tissue in periosteum by creating periosteal defects in 
the tibia of rabbits.58 After 14 days, the reactive tissues were harvested and implanted in rabbit 
medial condyle OCD with and without hyaluronan for 3 weeks and 3 months time periods. 
Empty defects, defects filled with hyaluronan were used as controls. The results showed that 
empty defect and hyaluronan groups were far from fully filled, while ectopic cartilage groups 
with and without hyaluronan were filled to the level of the adjacent cartilage 3 weeks after 
implantation. After 3 months, empty defects were partially filled with fibrous or 
fibrocartilaginous tissue, but the ectopic cartilage implanted groups (with or without hyaluronan) 
were almost fully filled with both fibrocartilaginous and hyaline cartilage. The modified 
O’Driscoll scores for empty defect and hyaluronan groups were 12.7±6.4 and 15.3±3.2, and the 
ectopic cartilage implanted defects without or with hyaluronan were 15.4±3.9 and 18.2±2.9. 
Rabbit chondrocytes-derived ECM scaffolds were studied by Jin et al.25 Rabbit chondrocytes 
were cultured for 3 weeks in pellet-type manner. The formed cartilage tissue were freeze-dried 
and used as scaffolds for culture of rabbit chondrocytes for varied time periods (2-day, 2-week 
and 4-week groups). The constructs were then applied in OC regeneration in rabbit patellar 
grooves for 1 and 3 months. Untreated defects were used as control. After 1 month, the 2-week 
and 4-week groups were repaired with hyaline cartilage like tissue, while fibrocartilage tissues 
were observed in the control and the 2-day groups. After 3 months, the 4-week group presented 
striking features of hyaline cartilage, with a mature matrix and a columnar arrangement of 
chondrocytes. This group also displayed prominently zonal distribution of Col II, the highest 
International Cartilage Repair Society score among all the groups, and well restored subchondral 
bone. 
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    Decellularized OC tissue and non-OC tissues were also used for OC regeneration. Yagihashi 
et al. filled the rabbit patellar fossa OCD with decellularized bovine dentin matrix (50 or 100 mg 
per defect) for 1 to 9 weeks.59 Untreated defects served as control. After 3 weeks, the 100 mg 
group had higher new bone formation compared with the other groups, but the difference 
decreased with time. The 100-mg group showed better cartilage regeneration compared with the 
other groups, with hyaline cartilage in the peripheral area after 6 weeks and hyaline cartilage 
with similar thickness to the normal one after 9 weeks. Yang et al. produced a bilayered scaffold 
consisting of a decellularized cartilage matrix layer (chondral part) and a decellularized 
cancellous bone matrix layer (bony part).60 Canine BMSCs were chondrogenically differentiated 
for 14 days and then seeded onto the chondral part of the bilayered scaffolds. The constructs 
were implanted in canine bilateral femoral condyle for 3 and 6 months after in vitro culture for 4 
days. Scaffolds without cells were implanted as control. Results displayed that the macroscopic 
and histological grading scores of the experimental group were always higher than those of the 
control group. The scores for experimental group after 6 months showed higher values than those 
after 3 months. The stiffness of the neocartilage and subchondral bone in the experimental group 
was 70.77% and 74.95% of the ones of normal tissues, respectively. GAG content of the 
experimental group was 84.82% of the one of native cartilage. Regular and mature subchondral 
bone formed at both time points in the two groups.  
    Successful decellularization procedure allows the application of allogeneic or xenogeneic 
ECM scaffolds for OC regeneration. However, the mechanical properties of the ECM derived 
scaffolds are normally lower than the ones of the original tissues, due to the decellularization 
process. Development of composite scaffolds consisting of ECM and other synthetic 
biomaterials may provide a solution to overcome this limitation. 
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Layered scaffolds 
Similar to the in vitro studies, layered scaffolds were investigated intensively for in vivo OC 
regeneration using acellular or cellular strategy. 
    In our recent study, bilayered Silk/Silk-NanoCaP scaffolds were developed and implanted in 
rabbit knee condyle OCD for 4 weeks in an acellular strategy.61 Neocartilage formation in the 
chondral layer and abundant subchondral bone ingrowth in the bony layer of the bilayered 
scaffolds were observed (Figure 2). Jiang et al. developed bilayered poly(D-lactic acid) (PDLA) 
(chondral layer) and PDLA/tricalcium phosphate (bony layer) scaffolds. Autologous porcine 
chondrocytes were seeded into the chondral layer of the bilayered scaffolds and then the 
constructs were implanted by press-fit method in porcine medial/lateral femoral condyle OCD 
for 6 months.62 Scaffolds without cells served as control. The results of the experimental group 
showed that the scaffold retained in the center and cancellous bone formed in the periphery of 
the osseous layer. In the chondral phase, hyaline cartilage regeneration was confirmed by the 
positive Col II and Safranin O staining. Only fibrous tissue formed in the scaffold alone group. 
Both groups supported subchondral bone regeneration and mineralization. Shao et al. 
incorporated allogenic rabbit BMSCs into bilayered PCL and PCL/tricalcium phosphate (TCP) 
scaffolds by using fibrin gel and then implanted the scaffolds in rabbit medial femoral condyle 
OCD for 3 and 6 months.63 Scaffolds without cells were used as control. The experimental group 
displayed superior repair results as compared with the control group. Bone regeneration was 
good and consistent at both time points. After 3 months, all samples presented mixtures of 
neocartilage tissue and scaffold. After 6 months, some samples showed degradation while others 
presented normal cartilage appearance. 
 
Page 21 of 61
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 22
 
Figure 2. Silk based bilayered scaffold for OC regeneration in rabbit femur condyle after 
implantation for 4 weeks. (A) Macroscopic image of the bilayered scaffold. (B) Masson’s 
trichrome staining of the explants. The black arrows indicate neocartilage formation in the silk 
layer and the white arrow indicates new subchondral bone formation inside the silk-nanoCaP. 
(C) Safranin O staining in the silk layer of the explants. It was revealed that abundant GAG and 
proteoglycan formed in the inner domain of the silk layer. Arrow indicates chondrocytes. (D) 
Masson’s trichrome staining of the silk-nanoCaP layer in the explants. Arrow indicates new 
vessel formation. (E) Col II staining (fluorescent immunohistochemistry) in the silk layer of the 
explants. Arrow indicates Col II (red), while scaffold was stained blue. (F) SNA-lectin 
immunohistochemical staining for the endothelial cells invading the silk-nanoCaP layer. Arrow 
indicates vessels. ‘‘NB’’ indicates new bone inside the scaffold, ‘‘S’’ indicates scaffold. Adapted 
from Reference (61), with permission from Elsevier. 
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    Multilayered scaffolds were also studied by in vivo models.50, 64, 65 Tri-layered scaffold was 
generated by Tampieri et al., which contained an upper layer of collagen/hyaluronan, a lower 
layer of biomineralized collagen, and a intermediate layer of biomineralized collagen with lower 
extent of mineral.50 The tri-layered structure of the scaffold mimicked the cartilage, tidemark and 
subchondral bone regions in OC tissue. Ewe BMSCs were seeded onto the scaffolds and the 
constructs were subcutaneously implanted in nude mice for 8 weeks. The results revealed that 
cartilaginous matrix deposition was observed only in the loose chondral layer, and bone tissue 
was only formed in the subchondral layer. In the study from Da et al., one compact PLGA/TCP 
layer was generated between the porous decellularized bovine cartilage ECM layer (chondral 
layer) and the porous PLGA/TCP layer (bony layer).64 These scaffolds presented superior anti-
tensile and anti-shear properties to the control scaffold without compact layer. Rabbit BMSCs 
after osteogenic or chondrogenic differentiation for 21 days were seeded onto the bony and 
chondral parts of the scaffolds, respectively. The constructs after 3 days culture in DMEM were 
implanted in OCD in rabbit patellofemoral groove for 3 and 6 months. Bilayered scaffolds 
without compact layer were used as control. The results showed that the higher macroscopic 
scores, GAG and collagen contents, as well as superior histological results were observed in the 
scaffolds containing compact layer compared with the control. 
 
Biological cues 
Biological cues have been introduced into the scaffolds for the purpose of enhancing 
chondrocyte proliferation, or guiding the progenitor cells to mature and subsequently form 
healthy OC tissues.  
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    A representative method is the incorporation of growth factors in the scaffolds. Huang et al. 
combined the basic fibroblast growth factor (bFGF) in the poly(L-lactic acid)/amorphous 
calcium phosphate (ACP/PLLA) hybrid scaffolds and implanted these scaffolds in rabbit femoral 
condyle OCD for 4 and 12 weeks.66 Untreated defects and PLLA scaffolds incorporated with 
bFGF were used as controls. The results showed that PLLA group presented better defect filling 
compared with untreated group. Mainly fibrocartilage and limited bone formation were observed 
in the PLLA scaffolds. Additionally, only a little amount of Col II and no aggrecan genes were 
measured for this group. In the case of ACP/PLLA group, most of the defects were filled with 
well-established cartilage tissue with large amount cartilaginous ECM. Positive Col II staining 
was observed, and high level of Col II and aggrecan genes were detected.  
    In order to control the release profile, growth factors could be loaded firstly into microspheres 
and then incorporated in the scaffolds for OC repair.67, 68 In the study of Reyes et al., PLGA 
microsphere incorporating TGF-β1 or BMP-2 were loaded in the top alginate layer of the 
bilayered alginate/PLGA scaffolds.67 The bilayered scaffolds with 2.5 µg or 5 µg BMP-2, or 50 
ng TGF-β1 in the alginate layer were implanted in rabbit medial condyle OCD for 2, 6, 12 and 
24 weeks. Empty defects and unloaded scaffolds served as controls. After 6 weeks, all growth 
factor-treated groups displayed clear signs of defect repair, with complete repair of subchondral 
bone and good quality cartilage in most of the cases. In week 12, remarkably regeneration 
improvements in cartilage were observed between the untreated and growth factor-treated 
specimens, especially with TGF-β1 and 5 µg BMP-2 groups. All the growth factor-treated 
groups exhibited typical hyaline cartilage and regular surface in the defects. The results in week 
24 were similar with the ones in week 12. Kim et al. combined IGF-1and/or TGF-β3 loaded 
gelatin microparticles in the chondral layer of the bilayered OPF hydrogels.69 The chondral OPF 
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layer was 1 mm in thickness. Four groups of hydrogels were developed: Control without growth 
factor; microparticles loaded IGF-1; microparticle loaded IGF-1 and gel-loaded TGF-β3; 
microparticles-loaded IGF-1 and microparticles-loaded TGF-β3. The bilayered hydrogels were 
implanted in rabbit medial femoral condyles for 12 weeks. The results revealed that all the 
groups showed improvement in cartilage morphology compared with the control. Single delivery 
of IGF-1 displayed higher scores in subchondral bone morphology, improved chondrocytes and 
GAG amounts in adjacent cartilage tissue when compared with a dual delivery of IGF-1 and 
TGF-β3.  
    Gradient growth factors loading strategy was applied for in vivo OC interface regeneration.70, 
71 Mohan et al. developed PLGA microsphere based scaffolds with continuous gradients in the 
loaded growth factors and material composition.71 The scaffold was composed of a chondral 
layer of TGF-β1 loaded PLGA microspheres, a bony layer of BMP-2 loaded PLGA or 
PLGA/HA microspheres, and a gradient transition of the two layers in the middle. Blank PLGA 
scaffolds and blank gradient PLGA and PLGA/HA scaffolds (without growth factors) were used 
as controls. The four groups of scaffolds were implanted in rabbit medial condyle OCD for 6 and 
12 weeks. The gross morphology, MRI and histology data showed that the greatest extent of 
regeneration of cartilage and subchondral bone were achieved by the gradient PLGA and 
PLGA/HA scaffolds with growth factors loading. This group presented similar GAG content and 
cartilage thickness to the ones of the native cartilage, as well as higher bone filling and better 
edge integration with host bone compared with the other groups.  
    The platelet-rich plasma (PRP) contains a pool of growth factors and is considered as a 
promising alternative to commercial growth factors.72-74 Comparison of the PRP scaffolds seeded 
with BMSCs or ADSCs for OC regeneration was performed by Xie et al.73 The cells suspension 
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was mixed with PRP first and then the PRP would formed a fibrin clot by the activation of 
calcium from the medium. The BMSCs/PRP or ADSCs/PRP constructs were cultured in vitro for 
3 weeks and also implanted in male rabbit patellar groove OCD for 6, 9 and 12 weeks. PRP 
alone and untreated defects served as controls. The in vitro results showed that the BMSCs 
constructs exhibited higher proliferation rate, enhanced expressions of cartilage-specific genes 
and proteins compared with the ADSCs constructs. Regarding the in vivo study outcomes, the 
BMSCs seeded scaffolds displayed better gross appearance, histological and 
immunohistochemical characteristics, higher cartilage-specific genes and protein expressions, 
and superior subchondral bone regeneration compared with the other groups. This study has thus 
shown that PRP constructs can induce the differentiation of the seeded ASC into functional 
chondrocytes in vivo.  
Apart from the growth factors, gene delivery was also employed for OC regeneration. Chen et 
al. generated a plasmid TGF-β1 containing chitosan-gelatin scaffold as chondral part and a 
plasmid BMP-2 loaded HA/chitosan-gelatin scaffold as subchondral bone part.75 Rabbit BMSCs 
were seeded onto the chondral or the osteochondral bone part and the constructs were separately 
cultured for one week. Afterwards, a bilayered gene-activated scaffold was generated by 
combining the chondral and subchondral bone constructs with fibrin gel and subsequently the 
bilayered constructs were cultured in vitro for two weeks. The bilayered constructs were then 
implanted in rabbit patellar groove OCD for 4, 8 and 12 weeks. Scaffolds without plasmids, 
mono layer scaffolds with TGF-β1 or BMP-2 gene were also implanted. Empty defects were 
used as control. The in vitro result showed that high level of TGF-β1 and BMP-2 protein 
secretions by the seeded BMSCs were observed in the chondral layer and the subchondral layer, 
respectively. Regarding the in vivo outcomes, the monolayer scaffolds with BMP-2 gene 
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presented complete trabecular bone ingrowth within subchondral bone region and good 
integration with native bone tissue, but abundant Col I in the cartilage part. The monolayer 
scaffolds with TGF-β1 gene showed similar cartilage surface with native cartilage, while the 
regeneration of subchondral bone was insufficient. The bilayered scaffolds incorporated with 
genes simultaneously supported the regeneration of articular cartilage and subchondral bone 
under a spatially controlled manner after implantation for 12 weeks.  
In OC regeneration, the terminal differentiation of BMSCs often brings adverse outcomes. To 
address this issue, intra-articular injection of parathyroid hormone-related protein (PTHrP) 
together with implantation of bilayered collagen (chondral layer) and silk-HA (bony layer) 
scaffolds in rabbit patellar groove OCD for 16 weeks was performed by Zhang et al.76 The 
injection of PTHrP was carried out at three time windows (4-6, 7-9, and 10-12 weeks) every 7 
days after implantation. PBS was injected as control. It was found that defects treated with 
PTHrP at the 4-6 weeks time window exhibited better regeneration (reconstitution of cartilage 
and subchondral bone), minimal terminal differentiation (hypertrophy, ossification and matrix 
degradation), as well as enhanced chondrogenesis (cell shape, collagen II, and GAG content), 
compared with treatments at other time windows and control. The timing also influenced PTHrP 
receptor expression. 
 In the future, clinically relevant doses of growth factors or other bioactive factors and 
possibilities for their controlled release for OC regeneration should be further investigated. 
 
Gene transfection 
The incorporation of bioactive factors in scaffolds for OC regeneration is subject to many 
complicated aspects, such as carrier properties, encapsulation efficiency and shelf life of the 
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drugs. Production of these active factors by the cells is an attractive method. For this purpose, the 
gene transfer technology has been used for OC regeneration.75, 77-84  
Ueblacker et al. performed the transfection of rabbit chondrocytes with lacZ gene which was 
fused with tetracycline-responsible element (TRE).84 The gene expression of the transfected cells 
was controlled by the non-toxic drug, such as tetracycline or doxycycline. The transfected cells 
were seeded into collagen sponges and subsequently implanted in the rabbit femur patellar 
groove OCD for 4 weeks. The lacZ gene expression can be detected for 3 weeks with 
doxycycline treatment. The implants were integrated well with the host tissue. This study 
provided new insights for regulation of gene expression for OCD treatment.  
Producing growth factors by engineered cells has been studied. Chen et al. transduced de-
differentiated rabbit chondrocytes with recombinant baculovirus expressing BMP-2 and seeded 
the engineered cells onto PGA scaffolds.77 The scaffolds were cultured in a rotating bioreactor 
for 0, 1 and 3 weeks. The constructs were then implanted into rabbit knee patellar groove OCD 
for 8 weeks. Mock-transduced constructs without bioreactor culture were implanted as control. 
In vitro results showed that increased time led to more mature cartilaginous constructs. 
Regarding the in vivo results, the control group did not showed any repair of the defect. The 0 
week constructs (without bioreactor culture) resulted in incomplete regeneration of the defect. 
The 1 week constructs presented neocartilage layer rich in GAG and Col II, while non-complete 
integration between the graft and host cartilage. The 3 week constructs displayed regeneration of 
hyaline cartilage, improved integration, Col II and GAG rich matrixes. Madry et al. transfected 
the lacZ gene (control) and human IGF-I cDNA to allogenic lapine articular chondrocytes.83 The 
cells were cultured in PGA scaffolds in a rotating bioreactor for 10 or 28 days. The constructs 
were then implanted into OCD of rabbit knee patellar groove for 28 weeks. It was found that 
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engineered cartilage with genetically modified chondrocytes (overexpressing human IGF-I) 
markedly enhance the repair of OCD compared with the control group. The longer in vitro 
culture time led to superior OC regeneration outcomes and resulted in significantly decreased 
osteoarthritic changes in the neighboring tissue of the defects. In the future, more investigations 
on the optimization of introduced genes, improvement of transfection efficiency, and modulation 
of the transfected gene expression should be performed. 
 
External stimulus 
Besides the scaffolds, cells and biological cues, the external stimulus (such as mechanical 
stimulus) is also important for the healing of OC tissues.85, 86 Chang et al. implanted acellular 
PLGA scaffolds in rabbit femoral condyle OCD for 4 and 12 weeks. Immobilization (Imm), 
intermittent active motion (IAM), and continued positive motion (CPM) treatments were 
performed on the rabbits in the day following the surgery.93 Empty defects were used as control. 
After 12 weeks, the CPM group presented the best outcome with normal articular surfaces and 
no contracture in the joint. While Imm and IAM groups showed degenerated joints, abrasion 
cartilage surface and synovitis. The CPM group also showed significantly higher bone volume 
compared with the other groups. These results implied that the post-surgery physical stimulus 
synergistically contributed to the healing of OCD. Other external physical treatments are worthy 
to be explored in OC tissue engineering, such as electrical and magnetic stimuli, acupuncture and 
so on. 
 
Clinical Studies on OC Tissue Engineering 
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Table 1. Clinical Studies on OC Tissue Engineering  
Scaffolds/Cells 
Defect site 
Follow up time 
Patient number 
Type of study 
● Success rate 
▲ Advantages 
▼ Disadvantages 
Ref 
Hyalograft C® 
scaffold with human 
autologous 
chondrocytes 
(MACI) 
Ankle 
12 and 36 months 
46 
Prospective 
 
● The preoperative AOFAS score was 
57.2±14.3. After 12 and 36 months, the 
scores were 86.8±13.4 and 89.5±13.4, 
respectively.  
▲ The histological staining (blinded 
analysis) revealed that hyaline-like cartilage 
was formed. 
20 
Biphasic collagenous 
scaffold with 
autologous 
chondrocytes 
(MACI) 
Knee 
6 and 12 months 
30 
 Prospective 
● The IKDC scores increased from 24 to 44 
and 66 after 6 months and 1 year post-
operation, respectively. The MOCART score 
(blinded analysis) was improved from 11.5 
(6 months) to 13 (1 year). 
▲ Good clinical results were achieved even 
when MACI as a second-line procedure. 
87 
 
Col I/III bilayered 
membrane with 
autologous 
chondrocytes 
(MACI) 
Ankle 
1 and 2 years 
10 
Prospective 
 
● The AOFAS scores increased from 61.2 
(preoperative, ranged from 42-76) to 74.7 (1 
year postoperative, ranged from 46-87) and 
73.3 (2 year postoperative, ranged from 42-
90).  
▲ MACI may be an effective treatment for 
full-thickness lesions in talus without 
malleolar osteotomy. 
89 
 
Porcine Col I 
scaffold with 
autologous 
chondrocytes 
(MACI) 
Ankle 
Mean 24.5 months 
18 
Prospective 
 
● For AOFAS score, 64% were rated as 
excellent/good, whereas 36% were rated 
fair/poor. The FFI pain and disability, 
AOFAS, AAOS scores were 5.5 ± 2.0, 5.0 ± 
2.3, 58.6 ± 16.1 and 59.9 ± 16.0 before 
MACI. After MACI, these scores were 28 ± 
2.2, 2.6 ± 2.2, 80.4 ± 14.1 and 83.5 ± 13.2, 
respectively. MOCART score (blinded 
analysis) was 62.4±15.8. 
▲ MACI is a safe procedure for the 
treatment of OCD in the ankle. 
90 
 
Type I/III Col 
membrane with 
autologous 
chondrocytes 
(MACI) 
Knee 
1 year 
5 
Prospective 
▲ Pain reduction and significant 
improvement in function were observed after 
the MACI. 
85 
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Table 1. Continued (1) 
Scaffold/Cell 
Defect site 
Follow up Time 
Patient number 
Type of study 
● Success rate 
▲ Advantages 
▼ Disadvantages 
Ref 
Col powder or 
hyaluronan 
membrane loaded 
with concentrated 
BMSCs 
(MASI) 
 
Ankle 
6, 12, 18 and 24 
months 
23 (Col) 
25 (Hyaluronan) 
Prospective 
● In Col group, the AOFAS score was 
62.5±18 pre-operation and increased to 
89.8±9.8, 24 months post-operation. In the 
hyaluronan group, the scores increased from 
66.2±10.5 to 92.8±5.3, 24 months post-
operation.  
▲ One-step procedure using concentrated 
BMSCs, scaffolds and platelet gel for OCD 
treatment. MRI showed restoration in 
cartilage and subchondral bone after 2 years. 
24 
 
Trufit® 
 
Patella 
6 to 24 months 
10 
Prospective 
 
● After one year follow-up, the results were 
satisfactory in 80% patients.  
▲ One-step procedure for OCD treatment. 
▼ After 18 months follow up, 9 patients 
suffered pain and knee swelling. 
Reoperation rate for implant failure reached 
70%. MRI screened at final follow up 
showed a cylindrical cavity of fibrous tissue 
instead of subchondral bone ingrowth. 
21 
 
Multilayered 
scaffold contains 
PLGA, PGA, and 
calcium sulphate 
(Trufit BGS® plug) 
Knee 
6-39 months 
26 
 
 
▲ The plug demonstrated flush morphology 
at early (≤6 months) and longer follow-up 
(≥16 months), T2 relaxation times of the 
plug approached those of normal articular 
cartilage at longer follow up. 
▼ The plug presented deteriorated 
appearance at ~12 months follow-up. 
88 
 
Trufit BGS® plug Knee (donor sites 
after subchondral 
transplantation) 
2-63 months 
9 
 
● Post-operation, the CT scan showed 
decrease in the House Units from 84 (4 
months) to 19 (13 months). The ossification 
quality score was 1 (soft-tissue density) 
instead of 4 (cancellous bone).  
▼ No evidence of bone ingrowth, 
ossification or osteoconductivity. The 
density of the donor sites declined over time.  
91 
 
 
Trufit® plug Knee 
6 and 12 months 
20 
Prospective 
▲ The short-term clinical and MRI results 
were modest. No deterioration of the 
repaired tissue was observed.  
▼ 3 of the 15 patients failed and had to 
undergo autologous OC transplantation. 
94 
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Table 1. Continued (2) 
Scaffold/Cell 
Defect site 
Follow up Time 
Patient number 
Type of study 
● Success rate 
▲ Advantages 
▼ Disadvantages 
Ref 
Multilayered nano-
composite scaffold 
containing Col and 
Col/HA scaffold 
(MaioRegen®) 
Knee 
6 months 
13 (15 defects) 
Prospective 
 
● 4-5 weeks post-operation, 86.7% lesions 
were of completely attached graft and repair 
tissue. Complete filling of the cartilage 
defect and congruency of the articular 
surface were seen in 10 defects after 6 
months. 13.3% detachment was observed. 
▲ Histological analysis showed the 
formation of subchondral bone without the 
presence of materials. 
▼ Oedema or sclerosis in subchondral bone 
was presented in 8 defects. 
22 
MaioRegen® Knee 
6, 12, and 24 
months 
30 
Prospective 
 
● IKDC objective score changed from 
50.0% (preoperation) to 96.4% and 85.7% 
at 12 and 24 months follow up, 
respectively. The mean Tegner score was 
1.6±1.1 preoperative, 4.0±1.6, and 4.0±1.8 
at the 12 months and after 2 years follow 
up. Complete filling of the cartilage and 
integration of the graft were observed in 
70% of the lesions. 
▼ Only 7% of the subchondral lamina and 
47% of the bone were considered intact. 
92 
 
MaioRegen® 
and HYAFF® -11 
Knee 
2-3 years 
8(MaioRegen®) 
7(HYAFF®-11) 
 
● When MaioRegen® was used, the IKDC 
score improved from around 40 
(preoperation) to around 80 (postoperation). 
The Tegner score also increased 
significantly after the implantation. In case 
of HYAFF® -11, both the IKDC and 
Tegner scores were significantly improved. 
95 
 
 
Bilayered 
PLGA/PLGA-TCP 
scaffolds with a 
chamber between the 
two layers loading  
autologous 
chondrocytes  
Knee 
3, 6, 12, and 24 
months 
10 
Prospective 
● Postoperative KOOS in “symptoms” only 
significantly higher than the pre-operative 
value after 24 months. Whereas the other 
four subscales of KOOS were significantly 
higher than pre-operation values after 12 
and 24 months. 
▲ Defects were completely filled and 
regenerated cartilaginous surfaces flushed 
with surrounding native joint surface. The 
regenerated cartilage appeared hyaline. 
96 
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Tissue engineering approaches have already shown its charm in clinical OC regeneration. Table 
1 summarized the clinical studies on OC tissue engineering.20-22, 24, 87-96 These approaches include 
MACI, matrix-associated stem cell implantation (MASI) and layered scaffold implantation. 
MACI and MASI 
MACI is the first application of tissue engineering for OC regeneration.97 For this procedure, 
autologous chondrocytes are combined with scaffolds first and subsequently implanted into the 
defects. Collagen and hyaluronic acid scaffolds have been widely used in MACI. These materials 
are superior regarding their biodegradation, biocompatibility and low immune response. 
However, they are disadvantageous for the weak mechanical properties.  
    Comparing with ACI, MACI is advantageous in minimizing the donor site and getting rid of 
periosteal harvesting and suturing. Some clinical studies showed that MACI is an efficient 
method for OCD treatments, both in ankle and knee lesions.20, 87 Giannini et al. showed that the 
hyaluronan scaffold and specifically designed instrumentation allowed arthroscopic implantation 
of chondrocytes in the ankle.20 In a study from Giza et al, MRI images (blinded analysis) showed 
the regeneration of articular cartilage and subchondral bone in a 19-months follow up after 
MACI using the collagen scaffolds.89 Even though there are many successful cases on MACI, the 
clinical results of this approach are significantly related with the quality of chondrocytes used 
and the patients’ conditions. Normally, the cells harvested in this method are of low yield and 
present limited long-term survival and regenerative capacity, specifically those from the elder 
patients.98 Pietschmann et al. reported that the morphologically abnormal cells led to the poor 
clinical outcome in MACI.87 Aurich et al. also mentioned that the age of the patient and the 
duration of symptoms had significant impacts on the clinical outcomes.90 Similar to ACI 
procedure, MACI also requires the harvesting of chondrocytes from cartilaginous tissue which 
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would induce secondary morbidity and increase the cost. Considering the limitation of 
autologous chondrocytes, other cell sources might be used as alternative, such as stem cells. 
    MASI has been explored as an alternative to MACI. In this method, the autologous 
chondrocytes are replaced by autologous stem cells, e.g. BMSCs or ADSCs.98 This new 
technology requires only a single operation and minimizes the invasion. Nejadnik et al. 
compared the clinical outcomes of autologous chondrocyte and BMSCs for cartilage 
regeneration (observational cohort study), and found that there were no differences in the two 
groups.99 Interestingly, they also found that the younger patients showed better outcomes in the 
ACI group, while the age did not make differences in the BMSCs group. Scaffolds seeded with 
concentrated bone marrow-derived cells were also investigated for OC regeneration in clinical 
trials.24 In another study, Kon et al. confirmed that the one-step bone marrow derived cell 
transplantation technology achieved good clinical and radiographic outcomes for patients with 
osteochondritis dissecans.95 Besides BMSCs and ADSCs, there are also other stem cells which 
are worthy to be explored, such as stem cells from synovium, muscle, amnionic fluid, umbilical 
cord blood, Wharton jelly and so on. 
 
Layered scaffolds 
The MACI and MASI approach focus on the regeneration of cartilage layer in OCD, and indeed 
they have demonstrated effectiveness for this purpose. While recent 5-year MRI follow-up 
showed that subchondral bone diseases (such as edema, cysts, sclerosis, and granulation) were 
observed in 50% of the patients who underwent MACI.3 This addresses the need for regeneration 
of subchondral bone together with the regeneration of cartilage layer in OC healing. Layered 
scaffolds, which mimics the structure and matrix component of OC tissue, provides a promising 
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option to overcome this problem.26 The implantation of layered scaffolds in OCD only requires 
one surgery and no need for fixation.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Biomimetic osteochondral scaffolds for clinical application (MaioRegen®). (A) 
Scaffolds morphology and components. (B-D) Images showing the surgical procedure: (B) 
cutting the scaffold, (C) the scaffold is templated using an aluminum foil to obtain the exact size 
of the graft needed, (D) implantation of the scaffold using a press-fit technique. Adapted from 
References (12) and (22), with permissions from SAGE and Elsevier, respectively. 
 
Currently, there are three artificial cell-free layered scaffolds available for clinical implantation 
in OCD: Trufit® CB plug, MaioRegen®, and Chondromimetic®. Trufit® CB plug is a 
cylindrical porous scaffold containing poly(lactic-co-glycolic acid) (PLGA), poly(glycolic acid) 
fiber and calcium sulfate. It is a press-fit implant, with tunable length and diameter ranging from 
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5 to 11 mm.88 MaioRegen® is a biomimetic three layer scaffold (Figure 3). The composition 
from the top layer to the bottom layer resembles the contents of collagen and hydroxyapatite in 
the cartilage, tidemark and the subchondral bone, respectively.22 Chondromimetic® is bilayered 
porous implant containing collagen, glycosaminoglycan, and calcium phosphate.100 There are no 
clinical reports on this product yet.  Comparing these three scaffolds, Trufit® CB plug composed 
of synthetic polymers may exhibit better mechanical properties than the other two scaffolds 
which mainly contain natural macromolecules. Good mechanical properties allow easy 
implantation and fixation of the scaffolds. On the other hand, the MaioRegen® and 
Chondromimetic® may display superior biocompatibility to Trufit® in terms of their 
degradation products and ability to guide cells’ differentiation. Table 1 listed the clinical 
outcomes of Trufit® and MaioRegen®. Both satisfactory and negative results were achieved. 
These varied clinical outcomes of the layered scaffolds may be related to the patients’ conditions 
(e.g., age, the site of lesion, the type and history of injury) and the intrinsic properties of the 
biomaterials. More evidences and further comparative studies are required to understand and 
relate all these aspects. 
Attempt combining layered scaffolds and autologous chondrocytes was performed by Chiang 
et al.96 Besides the healing of cartilage, it was also found that cancellous bone formed in the 
osseous phase without pre-seeding of cells. The biphasic scaffolds seeded with therapeutic 
autologous cells could be promising strategy for the treatment of OCD in the following. Specific 
cells might be loaded onto the corresponding layers, respectively. In order to circumvent the 
limitation of chondrocytes, cells derived from other sources could be used, e.g. ADSCs and 
BMSCs.   
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OC Tissue Engineering
Strategies Challenges
Clinical 
strategies
MACI
Two operations; fixation problem; donor site morbidity; non-sufficient 
subchondral bone regeneration.
MASI
Multi-steps on blood and bone marrow collection, platelet gel formation, 
and bone marrow concentration; Fixation problem; non-sufficient 
subchondral bone regeneration.
Layered scaffold without cells
Clinical results are preliminary; the influence of scaffold properties on 
long-term regeneration outcomes needs to be validated .
Combination of MACI and layered 
scaffold
Donor site morbidity; clinical results are preliminary; the long-term 
regeneration outcomes and influence of scaffold properties need to be 
validated.
Pre-clinical
strategies
Single layer or layered scaffold alone
Interaction between OCD regeneration outcomes and scaffolds 
properties (morphology, component, degradation') or external 
stimulus (mechanical, chemical') still needs to be elucidated.
Single layer or layered scaffold with 
cells
The influence of scaffolds properties (morphology, chemical 
components') on the cells phenotype or differentiation is not fully 
understood;  controlling the cell fate is still a substantial hindrance.
Single layer or layered scaffold with 
GF/Bioactive agents alone or 
GF/Bioactive agents and cells
The incorporation dose and release profile of GF/Bioactive agents 
need to be optimized; The long-term cells fate and regeneration 
outcome need to be validated. 
Challenges and Future Perspectives in OC Tissue Engineering 
Based on the amount of information gathered over the last few years while searching for 
effective strategies for OC regeneration, it is possible to comprehend the degree of complexity of 
this task and its limitations (Scheme 1). 
Scheme 1. Current tissue engineering strategies and challenges for OC regeneration. For pre-
clinical strategies, “scaffold” indicated porous scaffold or hydrogels with single layer or layered 
structure. 
 
In the future, the development of novel bioactive and biomimetic scaffolds for OC regeneration 
will remain a major issue. The ideal scaffold are those which can be easily integrated with host 
tissue and include signals to guide the proliferation and differentiation of specific cells to form 
normal stratified OC tissue. In order to provide a satisfactory environment for the fast formation 
of OC tissue, the components in the chondral and the subchondral layers of the scaffold should 
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resemble the ones in the counterpart of the OC tissue. Additionally, it is important that the 
structure and components of the scaffolds favor the continuous and integrated OC interface 
generation. Moreover, the scaffold must maintain its structural integrity when implanted and 
present a degradation profile matching the growth pace of the de novo tissues. During the 
regeneration, the scaffolds should be capable of preventing the invasion of synovial fluid to the 
subchondral bone and the vascularization in the chondral layer. 
To address these challenges, ECM-based biomaterials or synthetic ECM analogues are 
suitable components for scaffold preparation. In order to modulate the mechanical properties and 
degradation behavior of the scaffolds, controlling the conformations or the assembly process of 
biomacromolecules, introduction of degradable polymer as a reinforcing phase and regulation of 
the component ratios, are promising approaches. For the purpose of creating stratified and 
integrated OC tissue, layered scaffold with gradient transition in the varied phases is the optimal 
choice. Advanced processing methods are required to spatially control the structure and 
compositions in the scaffolds, specifically in the interface region.  
Since OCD is varied in each individual patient, the customized design of the scaffolds for 
patients is of great demand. For the generation of customized OC grafts in the in vitro system, 
please see previous review from Grayson et al.17 Nowadays, the computer-aided design and 
computer aided manufacture (CAD/CAM) technologies provide possibility to built scaffolds for 
specific individuals, no matter the shape and size of the defects (Figure 4).101, 102 In the 
following, these techniques should be used for the preparation of scaffolds from various 
materials (or composite), and even including bioactive factors and/or stem cells for clinical 
application. Before being transferred to the clinic, there are still many problems which should be 
solved, such as optimization of the clinically related incorporation dose and release profile of the 
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bioactive factors, harnessing the fate of stem cells in vivo and guiding them precisely towards 
OC differentiation. Furthermore, the application technique of the scaffold should be taken into  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Fabrication of customized biphasic scaffolds using CAD/CAM technology. The 
morphological information of the goat femoral head (A) was captured by laser scanning. The 3D 
data were reconstructed via the CAD software (B, C). PCL/HA scaffold (D, E) fabricated by 
fused deposition modeling (FDM) was designed to be with an intramedullary stem and 
interconnecting microchannels (H). The PGA/PLA scaffold (F) with relatively small pore size (I) 
was pressed into a hemispherical shape. The well-matched PGA/PLA scaffold and PCL/HA 
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scaffold formed a biphasic scaffold (G). Adapted from Reference (101), with permission from 
Elsevier. 
 
consideration, since non-invasive techniques (preferred by surgeons nowadays) imply 
dimensional constrains to the materials. 
    The selection of proper cells for OC regeneration constitutes another critical issue. Adult 
chondrocytes possess limited regenerative capacity and often undergo dedifferentiation. Adult 
stem cells are attractive cell sources, while still require invasive harvesting process and are 
associated with quality instability and low quantity. Other immature stem cells (such as AFSC 
and UCMSCs) present superior activity and differentiation ability as compared to adult stem 
cells, but there is a limited access to these cells. Embryonic stem cells (ESCs) possess unlimited 
differentiation capacity and have been used for cartilage regeneration.103 However, their 
application is still under ethical argument.  
    Recently, induced pluripotent stem cells (iPSCs), as an alternative to ESCs, have been 
investigated intensively.104 Different from the ESCs, iPSCs can be created from somatic cells 
and thus circumvent the ethical controversy of ESCs. The utility of iPSCs cells for OC 
regeneration is promising. Ko et al. at first compared the in vitro chondrogenic differentiation 
differences of human iPSCs (hiPSCs) and human BMSCs, and then applied the alginate gels 
encapsulating hiPSCs pellet or hiPSCs for OCD regeneration in the patellar groove of 
immunosuppressed rat for 12 weeks (Figure 5).105 Empty defects and defects filled alginate gels 
were used as controls. After in vitro culture for 21 days, the chondrogenic hiPSCs showed 
greater GAG contents and superior chondrocytic characteristics, significantly lower level of Col 
X and Col I compared with the chondro-induced BMSCs. Defects filled by alginate gels 
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incorporated with chondro-induced hiPSCs showed better cartilage regeneration than the empty 
defects or alginate alone group. For the next stage, more in vitro and in vivo studies should be 
conducted to compare the OC regeneration capacity between iPSCs and other adult stem cells, 
aiming to better understand the potential and control the differentiation of the iPSCs. For the 
optimization of the in vitro culture conditions, bioreactors might be used to provide consistent 
and adjusted environments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The application of human induced pluripotent stem cells (hiPSCs) for OC 
regeneration. (A) Safranin O staining of chondro-induced hiPSCs and human BMSCs (pellets 
and in alginate hydrogel) after 21 days. (B) In vivo repair of patellar OCD in immunosuppressed 
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rat after the implantation of chondro-induced hiPSCs for 12 weeks. Safranin O staining 
confirmed the cartilage regeneration in the hiPSCs containing groups. Adapted from Reference 
(105), with permission from Elsevier. 
 
Conclusions 
During the past few years, numerous advances have been achieved in OC tissue engineering. 
Tissue engineering strategies, despite introducing more complexity and details to the current 
treatments, present a high potential for OC regeneration. In fact, OC regeneration is an 
interdisciplinary topic and integrative strategy should be employed. High-throughput approaches 
may be applied in rapid materials screening, molecule tailoring, component combinations and 
structure optimizations for scaffold design. It would be helpful to create novel in vitro culture 
models (such as using bioreactors) and in vivo animal models which closely mimic the OC 
microenvironment of the patients, and then test different constructs in these systems and thus 
establish relationship of these results for guiding the clinical treatment. Although there are still 
many critical problems to be solved, tissue engineering still represents the most promising 
alternative for OC regeneration. 
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FDM: Fused deposition modeling; 
FFI: The Foot Function Index; 
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MACI: Matrix-associated chondrocyte implantation; 
MASI: Matrix-associated stem cells implantation; 
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PBT: Poly(butylene terephthalate); 
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TGF-β1: Transforming growth factor-β1; 
TGF-β3: Transforming growth factor-β3; 
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UCMSCs: Umbilical cord mesenchymal stromal cells. 
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The left is the micro-CT image of bilayered silk/silk-nanoCaP scaffolds recently developed by 
our group. This image clearly showed the silk matrix (brown) and the CaP phase (blue) 
distribution in the biphasic and well integrated scaffold. The right is the Masson’s trichrome 
staining image of the osteochondral explant after implantation of the left bilayered scaffold in 
rabbit OCD for 4 weeks. Black and white arrows indicate neocartilage tissue formed in the top 
silk layer and subchondral bone grew into the bottom silk-nanoCaP layer. These silk based 
bilayered scaffolds could be promising candidate for OC regeneration. 
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